BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22436788)

  • 41. Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
    Harkenrider MM; Patel R; Surucu M; Chinsky B; Mysz ML; Wood A; Ryan K; Shea SM; Small W; Roeske JC
    Brachytherapy; 2018; 17(5):747-752. PubMed ID: 29945764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects.
    Fellner C; Pötter R; Knocke TH; Wambersie A
    Radiother Oncol; 2001 Jan; 58(1):53-62. PubMed ID: 11165682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of heterogeneity-corrected dose calculation using a grid-based Boltzmann solver on breast and cervix cancer brachytherapy.
    Hofbauer J; Kirisits C; Resch A; Xu Y; Sturdza A; Pötter R; Nesvacil N
    J Contemp Brachytherapy; 2016 Apr; 8(2):143-9. PubMed ID: 27257419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.
    Chi A; Gao M; Sinacore J; Nguyen NP; Vali F; Albuquerque K
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):309-14. PubMed ID: 19540070
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors for predicting rectal dose of high-dose-rate intracavitary brachytherapy after pelvic irradiation in patients with cervical cancer: a retrospective study with radiography-based dosimetry.
    Huang EY; Wang CJ; Lan JH; Chen HC; Fang FM; Hsu HC; Huang YJ; Wang CY; Wang YM
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):490-5. PubMed ID: 19467795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of brachytherapy applicators geometry on dose distribution in cervical cancer.
    Senkus-Konefka E; Kobierska A; Jassem J; Serkies K; Badzio A
    Strahlenther Onkol; 1997 Jun; 173(6):323-9. PubMed ID: 9209530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early outcomes and impact of a hybrid IC/IS applicator for a new MRI-based cervical brachytherapy program.
    Harkenrider MM; Surucu M; Harmon G; Mysz ML; Shea SM; Yacoub J; Goldberg A; Liotta M; Winder A; Potkul R; Roeske JC; Small W
    Brachytherapy; 2018; 17(1):187-193. PubMed ID: 29089277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical design.
    Han DY; Webster MJ; Scanderbeg DJ; Yashar C; Choi D; Song B; Devic S; Ravi A; Song WY
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):666-73. PubMed ID: 24751413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative evaluation of two-dimensional radiography and three dimensional computed tomography based dose-volume parameters for high-dose-rate intracavitary brachytherapy of cervical cancer: a prospective study.
    Madan R; Pathy S; Subramani V; Sharma S; Mohanti BK; Chander S; Thulkar S; Kumar L; Dadhwal V
    Asian Pac J Cancer Prev; 2014; 15(11):4717-21. PubMed ID: 24969909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Image-based dose planning of intracavitary brachytherapy: registration of serial-imaging studies using deformable anatomic templates.
    Christensen GE; Carlson B; Chao KS; Yin P; Grigsby PW; Nguyen K; Dempsey JF; Lerma FA; Bae KT; Vannier MW; Williamson JF
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):227-43. PubMed ID: 11516873
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.
    Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A
    J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
    Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Techniques for and uncertainties of MRI-based reconstruction of titanium tandem and ring brachytherapy applicators.
    Malajovich I; Anamalayil S; Dolney OV; Kevin Teo BK; Arscott WT; Taunk NK
    Brachytherapy; 2020; 19(5):651-658. PubMed ID: 32624406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RapidBrachyDL: Rapid Radiation Dose Calculations in Brachytherapy Via Deep Learning.
    Mao X; Pineau J; Keyes R; Enger SA
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):802-812. PubMed ID: 32413546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the impact of absorbed dose specification, tissue heterogeneities, and applicator heterogeneities on Monte Carlo-based dosimetry of Ir-192, Se-75, and Yb-169 in conventional and intensity-modulated brachytherapy for the treatment of cervical cancer.
    Morcos M; Viswanathan AN; Enger SA
    Med Phys; 2021 May; 48(5):2604-2613. PubMed ID: 33619739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of intrafraction motion of the organs at risk in image-based brachytherapy of cervical cancer.
    Simha V; Patel FD; Sharma SC; Rai B; Oinam AS; krishnatry R; Dhanireddy B
    Brachytherapy; 2014; 13(6):562-7. PubMed ID: 25030951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A mathematical model to predict the different isodose volumes using TRAK value in HDR intracavitary brachytherapy for revised Manchester and ICRU-89 based Point A plans using computer tomography images.
    Mourya A; Choudhary S; Sharma N; Shahi UP; Singh G; Pradhan S; Aggarwal LM
    J Cancer Res Ther; 2022; 18(4):1105-1113. PubMed ID: 36149168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.